Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
This approach involves comprehensive molecular simulations of the catalytic and allosteric binding pockets and ensemble virtual screening that accounts for their conformational flexibility. In the case of designing modulators, the structural adjustments caused by reaction intermediates are considered to improve activity and selectivity.
Our library stands out due to several important features:
partner
Reaxense
upacc
P10153
UPID:
RNAS2_HUMAN
Alternative names:
Eosinophil-derived neurotoxin; RNase UpI-2; Ribonuclease 2; Ribonuclease US
Alternative UPACC:
P10153; Q52M39; Q9H2B7; Q9UCG7
Background:
The Non-secretory ribonuclease, also known as Eosinophil-derived neurotoxin, RNase UpI-2, Ribonuclease 2, and Ribonuclease US, is a pyrimidine-specific nuclease with a preference for uracil. It exhibits cytotoxic and helminthotoxic properties and is selectively chemotactic for dendritic cells. Its broad biological activities highlight its significance in various physiological processes.
Therapeutic significance:
Understanding the role of Non-secretory ribonuclease could open doors to potential therapeutic strategies. Its ability to target dendritic cells and its wide range of biological activities make it a promising candidate for the development of novel treatments.